Werewolf Therapeutics Highlights Initial Safety and Efficacy Data From Its Ongoing Phase 1 Clinical Trial Evaluating Wtx-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
Werewolf Therapeutics從其正在進行的Wtx-330在晚期或轉移性實體瘤或非何傑金淋巴瘤患者中的1期臨床試驗中突出了初始安全性和療效數據。